Genexine Inc
Genexine, Inc., together with its subsidiaries, operates as a biotechnology company that focuses on the development and commercialization of immunotherapies in South Korea and internationally. The company develops its products through its hybrid Fc platform, a proprietary technology designed to develop long-acting protein drugs; and the DNA vaccine platform that is used to elicit immune responses… Read more
Genexine Inc (095700) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.011x
Based on the latest financial reports, Genexine Inc (095700) has a cash flow conversion efficiency ratio of -0.011x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.97 Billion) by net assets (₩260.01 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Genexine Inc - Cash Flow Conversion Efficiency Trend (2009–2024)
This chart illustrates how Genexine Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Genexine Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Genexine Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
JADESTONE ENERGY LS -001
F:8KW
|
N/A |
|
Eugene Corporation
KQ:023410
|
0.011x |
|
Wendell Industrial Co. Ltd
TWO:6761
|
0.048x |
|
Bank Bukopin Tbk
JK:BBKP
|
-0.010x |
|
Chinese Maritime Transport Ltd
TW:2612
|
0.045x |
|
G8 Education Ltd
AU:GEM
|
0.097x |
|
Loncor Resources Inc
TO:LN
|
-0.046x |
|
Shining Building Business Co Ltd
TW:5531
|
0.004x |
Annual Cash Flow Conversion Efficiency for Genexine Inc (2009–2024)
The table below shows the annual cash flow conversion efficiency of Genexine Inc from 2009 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩261.68 Billion | ₩-1.65 Billion | -0.006x | +95.09% |
| 2023-12-31 | ₩296.90 Billion | ₩-38.05 Billion | -0.128x | +11.07% |
| 2022-12-31 | ₩276.15 Billion | ₩-39.80 Billion | -0.144x | -485.45% |
| 2021-12-31 | ₩517.74 Billion | ₩-12.75 Billion | -0.025x | +41.89% |
| 2020-12-31 | ₩535.60 Billion | ₩-22.69 Billion | -0.042x | +69.74% |
| 2019-12-31 | ₩296.91 Billion | ₩-41.57 Billion | -0.140x | -123.77% |
| 2018-12-31 | ₩320.51 Billion | ₩-20.05 Billion | -0.063x | +72.70% |
| 2017-12-31 | ₩113.91 Billion | ₩-26.10 Billion | -0.229x | -176.72% |
| 2016-12-31 | ₩170.24 Billion | ₩-14.10 Billion | -0.083x | -534.09% |
| 2015-12-31 | ₩125.77 Billion | ₩-1.64 Billion | -0.013x | -135.88% |
| 2012-12-31 | ₩45.83 Billion | ₩1.67 Billion | 0.036x | +125.17% |
| 2011-12-31 | ₩24.04 Billion | ₩-3.48 Billion | -0.145x | +17.18% |
| 2010-12-31 | ₩26.43 Billion | ₩-4.62 Billion | -0.175x | -19184.88% |
| 2009-12-31 | ₩38.50 Billion | ₩35.23 Million | 0.001x | -- |